Total Payments
$364,217
2024 Payments
$258,040
Companies
4
Transactions
35
Payment Breakdown by Category
Other$258,040 (70.8%)
Research$106,177 (29.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,040 | 12 | 70.8% |
| Unspecified | $106,177 | 23 | 29.2% |
Payments by Type
General
$258,040
12 transactions
Research
$106,177
23 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CIPLA USA INC. | $258,040 | 12 | $0 (2024) |
| Glenmark Pharmaceuticals Inc. | $103,565 | 12 | $0 (2018) |
| Chiesi USA, Inc. | $1,561 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,051 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258,040 | 12 | CIPLA USA INC. ($258,040) |
| 2022 | $1,561 | 3 | Chiesi USA, Inc. ($1,561) |
| 2018 | $48,965 | 7 | Glenmark Pharmaceuticals Inc. ($48,965) |
| 2017 | $55,651 | 13 | Glenmark Pharmaceuticals Inc. ($54,600) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,976.80 | General |
| 09/09/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $30,991.20 | General |
| 09/09/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| 08/13/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $44,438.40 | General |
| 08/13/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $85.60 | General |
| 06/28/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $43,741.60 | General |
| 06/28/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $22,700.48 | General |
| 06/28/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,696.00 | General |
| 06/28/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 06/14/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $33,665.60 | General |
| 02/23/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $39,800.00 | General |
| 02/23/2024 | CIPLA USA INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,424.49 | General |
| 08/06/2022 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $401.00 | Research |
| Study: CLI-05993AB8-02 | ||||||
| 08/06/2022 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $266.48 | Research |
| Study: CLI-05993AB8-02 | ||||||
| 08/05/2022 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $893.65 | Research |
| Study: CLI-05993AB8-02 | ||||||
| 09/17/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $10,984.40 | Research |
| 09/17/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,902.59 | Research |
| 09/17/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $3,800.00 | Research |
| 07/25/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $17,577.40 | Research |
| 07/18/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $5,944.30 | Research |
| 07/11/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $2,256.30 | Research |
| 06/06/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $3,500.00 | Research |
| 11/02/2017 | GlaxoSmithKline, LLC. | — | — | Cash or cash equivalent | $599.89 | Research |
| Study: A randomised, double blind, parallel group, multicentre, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate vilanterol inhalation powder compared to once daily fluticasone furoate inhalation powder in the treatment of a | ||||||
| 11/02/2017 | GlaxoSmithKline, LLC. | — | — | Cash or cash equivalent | $157.07 | Research |
| Study: A randomised, double blind, parallel group, multicentre, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate vilanterol inhalation powder compared to once daily fluticasone furoate inhalation powder in the treatment of a | ||||||
| 11/02/2017 | GlaxoSmithKline, LLC. | — | — | Cash or cash equivalent | $91.87 | Research |
| Study: A randomised, double blind, parallel group, multicentre, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate vilanterol inhalation powder compared to once daily fluticasone furoate inhalation powder in the treatment of a | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP 301-303 | Glenmark Pharmaceuticals Inc. | $54,600 | 5 |
| CLI-05993AB8-02 | Chiesi USA, Inc. | $1,561 | 3 |
| A randomised, double blind, parallel group, multicentre, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate vilanterol inhalation powder compared to once daily fluticasone furoate inhalation powder in the treatment of a | GlaxoSmithKline, LLC. | $1,051 | 8 |
About Dr. Karen Dunn, M.D
Dr. Karen Dunn, M.D is a Allergy & Immunology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417955022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Dunn, M.D has received a total of $364,217 in payments from pharmaceutical and medical device companies, with $258,040 received in 2024. These payments were reported across 35 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,040).
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Raleigh, NC
- Active Since 07/08/2005
- Last Updated 07/08/2007
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1417955022
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Raleigh
Craig Laforce, M.d, M.D
Allergy & Immunology — Payments: $250,539
Allergy & Immunology $250,539
Jonathan Romeo, Do, DO
Allergy & Immunology — Payments: $194,805
Allergy & Immunology $194,805
Dr. Laurie Mcwilliams, M.d, M.D
Allergy & Immunology — Payments: $93,811
Allergy & Immunology $93,811
Sonia Bains, Md, MD
Allergy & Immunology — Payments: $45,272
Allergy & Immunology $45,272
Gurvinder Deogun, Md, MD
Allergy & Immunology — Payments: $14,174
Allergy & Immunology $14,174
Dr. Maureen Petersen, M.d, M.D
Allergy & Immunology — Payments: $12,785
Allergy & Immunology $12,785